Why does this matter for GLP-1 therapy
Each dose is prepared by licensed 503A compounding pharmacies, ensuring pharmaceutical-grade purity and consistency without the cost premium of brand-name versions
These benefits include cardiovascular risk reduction, heart failure hospitalization rate reduction, kidney disease progression risk reduction, and weight loss
It also leads to inequities in employment, health care and educational achievement
Patients should not advance doses if experiencing significant gastrointestinal symptoms
Composite endpoints that include metabolic endpoints, validated psychological measures such as the PHQ-9 for depression, BES or measures of quality of life can better reflect improvements in both physical and mental health [41]